Dr Ying Zhu is a Senior Lecturer at the School of Biomedical Engineering, University of Technology Sydney (UTS), an Adjunct Fellow at the School of Clinical Medicine, UNSW Sydney, and the group leader of the Laboratory of In-Vitro NanoDiagnostics. She completed her PhD in optical biosensors in 2015 in Australia's leading biosensor and biodevice research group at UNSW, followed by postdoctoral training in clinical applications of biosensors at Dartmouth College's Thayer School of Engineering, US (2015–2017).

Ranked 3^rd in Australia for nanoplasmonic biosensing (SciVal), Dr Zhu has produced 33 publications garnering >1,300 citations (h-index 20), including a top 1% highly cited paper cited in an international clinical guideline. She has secured $2.68M in research funding as lead investigator on all 10 projects, including an ARC DECRA (2024), Cancer Institute NSW Early Career Fellowship (2017), 3 PanKind Innovation Grants, and three UTS Capital Expenditure Bids in research infrastructure. Her international standing is recognised by the 2025 Royal Society of Chemistry Sensors and Diagnostics Emerging Investigator Award, invitations to speak at the ISEV Annual Meeting Education Day as one of only three Australian speakers, and iCANX Talks, reaching a global audience of 16,400.

Dr Zhu serves as founding Associate Editor for Biosensors and Biomolecular Electronics (Springer Nature), Associate Editor for Cytometry Part A (Wiley), the only Australian on the Board Reviewers panel of the Journal of Extracellular Vesicles and an affiliated researcher of the ARC Research Hub for Molecular Biosensors at Point-of-Use (MOBIUS). She has supervised 30+ students, with 3 PhD completions, and has mentored 3 early-career researchers to secure ARC DECRA fellowships.